0 598

Cited 17 times in

Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components

DC Field Value Language
dc.contributor.author김재훈-
dc.contributor.author양우익-
dc.contributor.author조남훈-
dc.date.accessioned2015-07-14T16:42:20Z-
dc.date.available2015-07-14T16:42:20Z-
dc.date.issued2004-
dc.identifier.issn1048-891X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/111424-
dc.description.abstractWe experienced a case of primary malignant mixed müllerian tumors (MMMTs) of the fallopian tube of FIGO stage I. In addition to endometrioid adenocarcinomas, multiple apparent heterologous elements encompassing myxoid chondrosarcoma, osteosarcoma, myxoid liposarcoma, and well-differentiated angiosarcoma were recognized separately in each nodule. Those findings that divergent sarcomatoid differentiations are apparently present masquerading malignant mesenchymoma have not been described in MMMTs of the female genital tract.-
dc.description.statementOfResponsibilityopen-
dc.format.extent690~693-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAntineoplastic Agents/therapeutic use*-
dc.subject.MESHChemotherapy, Adjuvant/methods-
dc.subject.MESHFallopian Tube Neoplasms/pathology*-
dc.subject.MESHFallopian Tube Neoplasms/therapy-
dc.subject.MESHFemale-
dc.subject.MESHGynecologic Surgical Procedures/methods-
dc.subject.MESHHumans-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMixed Tumor, Mullerian/pathology*-
dc.subject.MESHMixed Tumor, Mullerian/therapy-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHTreatment Outcome-
dc.titleMalignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학)-
dc.contributor.googleauthorB. J. LIM-
dc.contributor.googleauthorJ. W. KIM-
dc.contributor.googleauthorN. H. CHO-
dc.contributor.googleauthorW. I. YANG-
dc.identifier.doi10.1111/j.1048-891X.2004.14432.x-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.relation.journalcodeJ01115-
dc.identifier.eissn1525-1438-
dc.identifier.pmid15304169-
dc.identifier.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00009577-200407000-00021&LSLINK=80&D=ovft-
dc.contributor.alternativeNameKim, Jae Hoon-
dc.contributor.alternativeNameYang, Woo Ick-
dc.contributor.alternativeNameCho, Nam Hoon-
dc.rights.accessRightsnot free-
dc.citation.volume14-
dc.citation.number4-
dc.citation.startPage690-
dc.citation.endPage693-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, Vol.14(4) : 690-693, 2004-
dc.identifier.rimsid35809-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.